„DRACO“ – Versionsunterschied

aus Wikipedia, der freien Enzyklopädie
Zur Navigation springen Zur Suche springen
[ungesichtete Version][ungesichtete Version]
Inhalt gelöscht Inhalt hinzugefügt
Tinton5 (Diskussion | Beiträge)
add cat
Istvan (Diskussion | Beiträge)
clean up ref1
Zeile 1: Zeile 1:
'''DRACO''' ("'''D'''ouble-stranded '''R'''NA (dsRNA) '''A'''ctivated '''C'''aspase '''O'''ligomerizer") is a group of experimental [[antiviral drug]]s under development at the [[Massachusetts Institute of Technology]]. DRACO is reported to have broad-spectrum efficacy against many types of infectious virii, including [[HIV]] and [[rhinovirus]]. DRACO is reported to induces rapid [[apoptosis]] selectively in virus-infected mammalian cells, while leaving uninfected cells unharmed.<ref>"Broad-Spectrum Antiviral Therapeutics" Todd H. Rider*, Christina E. Zook, Tara L. Boettcher, Scott T. Wick, Jennifer S. Pancoast, Benjamin D. Zusman Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, USA http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022572</ref><ref>"Greatest discovery since penicillin: A cure for everything - from colds to HIV" Fiona Macrae http://www.dailymail.co.uk/health/article-2024492/Greatest-discovery-penicillin-Scientists-work-drug-cure-viruses--including-flu.html</ref>
'''DRACO''' ("'''D'''ouble-stranded '''R'''NA (dsRNA) '''A'''ctivated '''C'''aspase '''O'''ligomerizer") is a group of experimental [[antiviral drug]]s under development at the [[Massachusetts Institute of Technology]]. DRACO is reported to have broad-spectrum efficacy against many types of infectious virii, including [[HIV]] and [[rhinovirus]]. DRACO is reported to induces rapid [[apoptosis]] selectively in virus-infected mammalian cells, while leaving uninfected cells unharmed.<ref name="PLoS ONE 1">{{cite journal |author=Todd H. Rider*, Christina E. Zook, Tara L. Boettcher, Scott T. Wick, Jennifer S. Pancoast, Benjamin D. Zusman |title=Broad-Spectrum Antiviral Therapeutics|journal=PLoS ONE |year=2011 |month=July |url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022572}}</ref><ref>"Greatest discovery since penicillin: A cure for everything - from colds to HIV" Fiona Macrae http://www.dailymail.co.uk/health/article-2024492/Greatest-discovery-penicillin-Scientists-work-drug-cure-viruses--including-flu.html</ref>


==References==
==References==

Version vom 11. August 2011, 05:44 Uhr

DRACO ("Double-stranded RNA (dsRNA) Activated Caspase Oligomerizer") is a group of experimental antiviral drugs under development at the Massachusetts Institute of Technology. DRACO is reported to have broad-spectrum efficacy against many types of infectious virii, including HIV and rhinovirus. DRACO is reported to induces rapid apoptosis selectively in virus-infected mammalian cells, while leaving uninfected cells unharmed.[1][2]

References

Vorlage:Reflist

  1. Todd H. Rider*, Christina E. Zook, Tara L. Boettcher, Scott T. Wick, Jennifer S. Pancoast, Benjamin D. Zusman: Broad-Spectrum Antiviral Therapeutics. In: PLoS ONE. Juli 2011 (plosone.org).
  2. "Greatest discovery since penicillin: A cure for everything - from colds to HIV" Fiona Macrae http://www.dailymail.co.uk/health/article-2024492/Greatest-discovery-penicillin-Scientists-work-drug-cure-viruses--including-flu.html